Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Dawnrays Pharmaceutical Holdings Ltd    2348   KYG2687M1006

DAWNRAYS PHARMACEUTICAL HOLDINGS LTD

(2348)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
05/17/2019 05/20/2019 05/21/2019 05/22/2019 05/23/2019 Date
1.38 1.38 1.39 1.42 1.38 Last
95000 395000 142000 98000 264000 Volume
+0.73% 0.00% +0.72% +2.16% -2.82% Change
Company
Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business... 
More about the company
Latest news on DAWNRAYS PHARMACEUTICAL HO
2018DAWNRAYS PHARMACEUTICAL HOLDINGS LTD : Ex-dividend day for interim dividend
FA
2018DAWNRAYS PHARMACEUTICAL HOLDINGS LTD : Ex-dividend day for extraordinary dividen..
FA
2018DAWNRAYS PHARMACEUTICAL HOLDINGS LTD : SPLIT: 2 of 1
FA
2018DAWNRAYS PHARMACEUTICAL : Pharma to consider special dividend payment
AQ
2018DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : Ex-dividend day for final dividend
FA
2018DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : annual earnings release
2017DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : Ex-dividend day for interim dividend
FA
2017DAWNRAYS PHARMACEUTICAL : Announcement of Interim Results for the six months end..
PU
2017DAWNRAYS PHARMACEUTICAL : Change in board lot size
PU
2017DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : Ex-dividend day for final dividend
FA
More news
Analyst Recommendations on DAWNRAYS PHARMACEUTICAL HO
More recommendations
Sector news : Pharmaceuticals - NEC
03:22aVECTURA : Awarded $2.5 Million from Novartis After Drug Makes Regulatory Progres..
DJ
05/23GLAXOSMITHKLINE : GSK brings back bonuses for some sales reps
RE
05/23GLAXOSMITHKLINE : GSK's shingles vaccine approved for use in China in adults age..
RE
05/23NOVARTIS : CEO says data quality, lagging innovation crimp China M&A
RE
05/23NOVARTIS : CEO says data quality, lagging innovation crimp China M&A
RE
More sector news : Pharmaceuticals - NEC
Chart DAWNRAYS PHARMACEUTICAL HOLDINGS LTD
Duration : Period :
Dawnrays Pharmaceutical Holdings Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAWNRAYS PHARMACEUTICAL HO
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers
NameTitle
Shao Jun Chen Chief Executive Officer & Executive Director
Kei Ling Li Chairman
Yung Lai Hung Executive Director
Hong Man Leung Non-Executive Director
Tung Sing Lo Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DAWNRAYS PHARMACEUTICAL HOLDINGS LTD-6.76%279
JOHNSON & JOHNSON7.52%368 416
PFIZER-3.80%233 461
ROCHE HOLDING LTD.9.84%228 186
NOVARTIS13.31%210 460
MERCK AND COMPANY5.98%208 495